Literature DB >> 7762082

Molecular determinants of Ca2+ channel function and drug action.

G Varadi1, Y Mori, G Mikala, A Schwartz.   

Abstract

Molecular cloning has revealed the existence of six high-voltage activated Ca2+ channel types. Expression studies have shown that basic high-voltage activated channel function, which is typical for the L-(skeletal muscle, cardiac muscle and neuroendocrine tissue), N-, P-, Q- and R-type channels is carried by the corresponding alpha 1 subunits. Auxiliary subunits, such as alpha 2/delta and beta, modulate the kinetics of activation, inactivation, current density and drug binding, thereby creating considerable potential for multiple Ca2+ channel functions. Glutamic acid residues in the pore (P) loops are molecular components that impart high selectivity for Ca+. Binding or pharmacologically active sites for Ca2+ channel drugs have been localized on various segments of the alpha 1 subunit in close proximity to the pore lining. In this article, Gyula Varadi and colleagues review the roles of the different subunits in Ca2+ channel function and suggest that Ca2+ channel drugs act by blocking or, in some cases, activating channel function via binding directly or indirectly to the pore structure of the channel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762082     DOI: 10.1016/s0165-6147(00)88977-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  31 in total

1.  Proportions of Ca2+ channel subtypes in chick or rat P2 fraction and NG108-15 cells using various Ca2+ blockers.

Authors:  Z Yu-an; T Imanishi; T Wada; S Ichida
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

2.  Auxiliary subunits operate as a molecular switch in determining gating behaviour of the unitary N-type Ca2+ channel current in Xenopus oocytes.

Authors:  M Wakamori; G Mikala; Y Mori
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

3.  Heart, calcium and time.

Authors:  Pavel Bravený
Journal:  Exp Clin Cardiol       Date:  2002

Review 4.  Age-associated alterations in calcium current and its modulation in cardiac myocytes.

Authors:  Y Y Zhou; E G Lakatta; R P Xiao
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

5.  A mutation affecting dihydropyridine-sensitive current levels and activation kinetics in Drosophila muscle and mammalian heart calcium channels.

Authors:  D Ren; H Xu; D F Eberl; M Chopra; L M Hall
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

6.  Corticosteroid regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons.

Authors:  S M Nair; T R Werkman; J Craig; R Finnell; M Joëls; J H Eberwine
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

7.  Intracellular Ca2+ inactivates L-type Ca2+ channels with a Hill coefficient of approximately 1 and an inhibition constant of approximately 4 microM by reducing channel's open probability.

Authors:  G F Höfer; K Hohenthanner; W Baumgartner; K Groschner; N Klugbauer; F Hofmann; C Romanin
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

8.  Voltage-dependent binding and calcium channel current inhibition by an anti-alpha 1D subunit antibody in rat dorsal root ganglion neurones and guinea-pig myocytes.

Authors:  C N Wyatt; V Campbell; J Brodbeck; N L Brice; K M Page; N S Berrow; K Brickley; C M Terracciano; R U Naqvi; K T MacLeod; A C Dolphin
Journal:  J Physiol       Date:  1997-07-15       Impact factor: 5.182

9.  Characteristics of the inhibitory effect of calmodulin on specific [125i]omega-conotoxin GVIA binding to crude membranes from chick brain.

Authors:  S Ichida; J Abe; Y A Zhang; K Sugihara; K Imoto; T Wada; N Fujita; H Sohma
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

10.  Critical role of conserved proline residues in the transmembrane segment 4 voltage sensor function and in the gating of L-type calcium channels.

Authors:  H Yamaguchi; J N Muth; M Varadi; A Schwartz; G Varadi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.